Diabetes Care, Vol 18, Issue 2 182-187, Copyright © 1995 by American Diabetes Association

ARTICLES

Incidence and determinants of elevated urinary albumin excretion in Pima Indians with NIDDM

RG Nelson, WC Knowler, DJ Pettitt, RL Hanson and PH Bennett
Department of Biostatistics and Epidemiology, Cleveland Clinic Foundation, USA.

OBJECTIVE--To examine the incidence and determinants of elevated urinary albumin excretion in Pima Indians with non-insulin-dependent diabetes mellitus (NIDDM). RESEARCH DESIGN AND METHODS--The incidence of elevated urinary albumin excretion (> or = 30 mg albumin/g creatinine) and its relationship with baseline characteristics was determined in 456 Pima Indians > or = 15 years old with NIDDM who were followed for up to 11.6 years (median 4.7 years). RESULTS--Of these 456 subjects, 192 (42%; 58 men, 134 women) developed elevated urinary albumin excretion, 172 of whom (90%) were within the microalbuminuric range (30-299 mg/g). The incidence of elevated urinary albumin excretion was related to retinopathy, type, of diabetes treatment, longer duration of diabetes, lower body mass index, and higher values of mean arterial pressure, HbA1, and fasting and 2-h postload plasma glucose concentration at the baseline examination, but not to sex. A relationship with cholesterol was found in durations of diabetes of > or = 10 years. The cumulative incidence of elevated albumin excretion was 17% after 5 years of NIDDM. CONCLUSIONS--The incidence of elevated urinary albumin excretion in Pima Indians with NIDDM is at least as high as that reported previously in insulin-dependent diabetes mellitus, and its major determinants are the same as those shown previously to predict the development of more advanced renal disease in this population.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				H. H. Otu, H. Can, D. Spentzos, R. G. Nelson, R. L. Hanson, H. C. Looker, W. C. Knowler, M. Monroy, T. A. Libermann, S. A. Karumanchi, et al. Prediction of Diabetic Nephropathy Using Urine Proteomic Profiling 10 Years Prior to Development of Nephropathy Diabetes Care, March 1, 2007; 30(3): 638 - 643. [Abstract] [Full Text] [PDF]

				J. L. Gross, M. J. de Azevedo, S. P. Silveiro, L. H. Canani, M. L. Caramori, and T. Zelmanovitz Diabetic Nephropathy: Diagnosis, Prevention, and Treatment Diabetes Care, January 1, 2005; 28(1): 164 - 176. [Abstract] [Full Text] [PDF]

				B. A. Young, J. A. Pugh, C. Maynard, and G. Reiber Diabetes and Renal Disease in Veterans Diabetes Care, May 1, 2004; 27(suppl_2): B45 - B49. [Abstract] [Full Text] [PDF]

				V. O. Shah, M. Scavini, C. A. Stidley, F. Tentori, T. K. Welty, J. W. MacCluer, A. S. Narva, A. Bobelu, C. P. Albert, D. S. Kessler, et al. Epidemic of Diabetic and Nondiabetic Renal Disease among the Zuni Indians: The Zuni Kidney Project J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1320 - 1329. [Abstract] [Full Text] [PDF]

				R. Trevisan, M. Vedovato, C. Mazzon, A. Coracina, E. Iori, A. Tiengo, and S. Del Prato Concomitance of Diabetic Retinopathy and Proteinuria Accelerates the Rate of Decline of Kidney Function in Type 2 Diabetic Patients Diabetes Care, November 1, 2002; 25(11): 2026 - 2031. [Abstract] [Full Text] [PDF]

				J. B. Meigs, R. B. D'Agostino Sr., D. M. Nathan, N. Rifai, and P. W.F. Wilson Longitudinal Association of Glycemia and Microalbuminuria: The Framingham Offspring Study Diabetes Care, June 1, 2002; 25(6): 977 - 983. [Abstract] [Full Text] [PDF]

				M. Murussi, P. Baglio, J. L. Gross, and S. P. Silveiro Risk Factors for Microalbuminuria and Macroalbuminuria in Type 2 Diabetic Patients: A 9-year follow-up study Diabetes Care, June 1, 2002; 25(6): 1101 - 1103. [Full Text] [PDF]

				K. V. LEMLEY, K. BLOUCH, I. ABDULLAH, D. B. BOOTHROYD, P. H. BENNETT, B. D. MYERS, and R. G. NELSON Glomerular Permselectivity at the Onset of Nephropathy in Type 2 Diabetes Mellitus J. Am. Soc. Nephrol., November 1, 2000; 11(11): 2095 - 2105. [Abstract] [Full Text]

				E. K. Hoogeveen, P. J. Kostense, P. E. D. Eysink, B. C. P. Polak, P. J. Beks, C. Jakobs, J. M. Dekker, G. Nijpels, R. J. Heine, L. M. Bouter, et al. Hyperhomocysteinemia Is Associated With the Presence of Retinopathy in Type 2 Diabetes Mellitus: The Hoorn Study Arch Intern Med, October 23, 2000; 160(19): 2984 - 2990. [Abstract] [Full Text] [PDF]

				The CDC Diabetes Cost-Effectiveness Study Group The Cost-effectiveness of Screening for Type 2 Diabetes JAMA, November 25, 1998; 280(20): 1757 - 1763. [Abstract] [Full Text] [PDF]

				A. Fagot-Campagna, R. L. Hanson, K. M. V. Narayan, M. L. Sievers, D. J. Pettitt, R. G. Nelson, and W. C. Knowler Serum Cholesterol and Mortality Rates in a Native American Population With Low Cholesterol Concentrations : A U-Shaped Association Circulation, September 2, 1997; 96(5): 1408 - 1415. [Abstract] [Full Text]

				M.-A. Gall, P. Hougaard, K. Borch-Johnsen, and H.-H. Parving Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study BMJ, March 15, 1997; 314(7083): 783 - 783. [Abstract] [Full Text]

				R. G. Nelson, P. H. Bennett, G. J. Beck, M. Tan, W. C. Knowler, W. E. Mitch, G. H. Hirschman, B. D. Myers, and The Diabetic Renal Disease Study Group Development and Progression of Renal Disease in Pima Indians with Non-Insulin-Dependent Diabetes Mellitus N. Engl. J. Med., November 28, 1996; 335(22): 1636 - 1642. [Abstract] [Full Text] [PDF]